Skip to main content

Table 3 Allodynia as a predictor for reduction in monthly migraine days (MMD) and monthly headache days (MHD)

From: Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort study

 

Overall allodynia

Spatial distribution

Type of stimulus

Difference (95% CI)

p

Difference (95% CI)

p

Difference (95% CI)

p

Reduction in MMD

Allodynia (no allodynia vs allodynia)

3.49

(0.95; 6.02)

0.007

      

No allodynia

versus cephalic allodynia

   

3.35

(0.24; 6.45)

0.035

   

versus extracephalic allodynia

   

4.96

(1.60; 8.32)

0.004

   

No allodynia

versus thermal allodynia only

      

2.02

(-2.19; 6.23)

0.348

versus mechanical + thermal allodynia

      

4.17

(1.06; 7.27)

0.009

versus mechanical allodynia only

      

5.22

(0.88; 9.55)

0.018

Reduction in MHD

 Allodynia (no allodynia vs allodynia)

1.30

(-1.00; 3.59)

0.267

      

No allodynia

versus cephalic allodynia

   

2.09

(-0.74; 4.91)

0.148

   

versus extracephalic allodynia

   

2.62

(-0.43; 5.66)

0.093

   

No allodynia

versus thermal allodynia only

      

2.57

(-1.24; 6.38)

0.187

versus mechanical + thermal allodynia

      

2.15

(-0.67; 4.97)

0.135

versus mechanical allodynia only

      

2.61

(-1.32; 6.54)

0.192

  1. MHD Monthly headache days, MMD Monthly migraine days
  2. Adjusted for: gender, age, depression and anxiety